Incorporation of safety pharmacology endpoints in the toxicological assessment of a potential diagnostic positron emission tomography (PET) imaging agent

Authors:
  • EHElla Hirani
    Ella Hirani
  • GDGrethe Daalsgard
    Grethe Daalsgard
  • SHSusan Hoppmann
    Susan Hoppmann
  • PEPaul Evans
    Paul Evans

Abstract
No abstract available